Physician profile
Michael F Githens
NPI 1063738532
$60,825.22
in general payments reported to CMS, 2019-2025
7 companies · $8,172 in 2025
The $8,172 reported for 2025 was more than what 76% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,266 · 2020: $2,500 · 2021: $6,419 · 2022: $4,832 · 2023: $29K · 2024: $2,784 · 2025: $8,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,000 · Travel and Lodging: $4,528 · Food and Beverage: $918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,362.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,000.00 |
| Travel and Lodging | $4,528.47 |
| Food and Beverage | $917.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $30,361.24 | 2022-2023 | Na |
| Synthes Gmbh | $27,210.60 | 2019-2025 | |
| Summit Surgical Corp. | $2,417.84 | 2021-2022 | |
| Depuy Synthes Sales INC. | $377.41 | 2019-2025 | Na, Trialtis |
| Osteocentric Technologies, INC. | $212.62 | 2019-2022 | |
| Smith+Nephew, INC. | $175.82 | 2019-2024 | Evos, Trigen |
| Next Science LLC | $69.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Githens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.